Oligomeric Hyaluronic Acid Market

The Oligomeric Hyaluronic Acid market was valued at approximately USD 1.8 billion in 2022 and is projected to reach USD 2.6 billion by 2030, growing at a CAGR of around 7%

Pages: 249

Format: PDF

Date: 11-2024

Oligomeric Hyaluronic Acid Market: Detailed Overview

Introduction

Oligomeric hyaluronic acid refers to short-chain hyaluronic acid molecules (usually with fewer than 1000 kDa), which possess unique properties that make them suitable for specific industrial applications, particularly in skincare and biomedical fields. This form of hyaluronic acid is distinguished by its ability to penetrate deeper into the skin, making it highly valued in cosmetic formulations, especially anti-aging and hydrating products. Its versatility also extends to medical and therapeutic applications, where it is used in tissue engineering, joint health treatments, and wound care.

The Oligomeric Hyaluronic Acid market was valued at approximately USD 1.8 billion in 2022 and is projected to reach USD 2.6 billion by 2030, growing at a CAGR of around 7% from 2023 to 2030​

Oligomeric hyaluronic acid refers to a form of hyaluronic acid made up of short-chain molecules, typically with molecular weights under 1000 kDa. Unlike the longer-chain hyaluronic acid found in the body, which can have a molecular weight of up to 1,000,000 kDa, oligomeric hyaluronic acid has the distinct ability to penetrate deeper into tissues, particularly the skin, providing rapid hydration and other therapeutic benefits.

It is commonly used in cosmetics, skincare products, and pharmaceutical applications, such as joint health treatments, wound healing, and tissue engineering. Its shorter molecular structure allows for more effective absorption into the skin, making it a popular ingredient in anti-aging and moisturizing products. In medicine, oligomeric hyaluronic acid is often found in injectable forms used for osteoarthritis treatment, promoting tissue regeneration and improving joint lubrication.

Report Attributes Details
Study Period 2023 to 2033
Base Year 2023
FORECAST PERIOD 2024-2030
HISTORICAL PERIOD 2020-2023
UNIT Value (USD Billion)
KEY COMPANIES PROFILED Givaudan Active Beauty
Kewpie Corp.
Evonik
Bloomage Biotechnology Corp., Ltd.
Focus Chem
Fufeng Group
AWA Biopharm
China Eastar Group
Contipro
Seikagaku
HTL Biotechnology
Fidia Farmaceutici
Zhejiang Green Creation Biotechnology Co., Ltd.
Shandong Liyang Biotechnology Co., Ltd.
Wanshun Chemical Materials
Others

SEGMENTS COVERED By Type, By Application, and By Geography
CUSTOMIZATION SCOPE Free report customization (equivalent to up to 4 analyst’s working days) with purchase. Addition or alteration to country, regional & segment scope.

Market Drivers

Increasing Demand in Cosmetics

Oligomeric hyaluronic acid is primarily used in cosmetic products for its skin hydration and anti-aging properties. The global demand for skincare products, particularly those that promote youthful skin, is a major factor propelling the market. This is due to the increased awareness of skin health and the aging population's desire for effective anti-aging solutions.

Rising Application in Medical and Therapeutic Uses

Oligomeric hyaluronic acid is also gaining popularity in the medical field for its role in tissue engineering, joint health, and wound healing. It is being increasingly used in treatments for osteoarthritis, where it acts as a lubricant and helps in the regeneration of damaged cartilage. Its use in injectable formulations for joint health and facial aesthetic procedures is boosting market growth.

Growing Awareness of Natural Ingredients

As consumers continue to lean towards natural and safe skincare solutions, products containing hyaluronic acid are experiencing growth due to its naturally occurring presence in the human body. This consumer preference is particularly evident in regions like North America and Europe, where there is a growing trend of using non-invasive beauty and healthcare products.

Key Market Segments

By Application

Cosmetics: Used in anti-aging creams, serums, and moisturizers.

Medical: Used in injectable therapies for joint care, wound healing, and ophthalmic surgeries.

Others: Includes potential applications in drug delivery systems and tissue engineering.

By End-User

Healthcare Providers: Hospitals, clinics, and specialized treatment centers use oligomeric hyaluronic acid for therapeutic purposes.

Cosmetic Manufacturers: Leading cosmetic brands are increasingly incorporating oligomeric hyaluronic acid in their skincare products.

Market Challenges Despite the market growth, some challenges include:

High Production Costs: The cost of synthesizing oligomeric hyaluronic acid is higher than that of its larger molecular counterparts, which can limit its use in more affordable products.

Regulatory Hurdles: Strict regulations and approval processes for medical applications, especially in injectable forms, can delay market entry and product innovation.

Competitive Landscape Key players in the oligomeric hyaluronic acid market include:

Hyalose: A leader in producing high-purity hyaluronic acid for both cosmetic and medical applications.

Contipro: Known for its innovative hyaluronic acid formulations in skincare products.

Shiseido: A major cosmetic company using oligomeric hyaluronic acid in anti-aging products.

Regional Insights

North America and Europe lead the market, driven by high consumer demand for skincare products and well-established medical applications.

Asia-Pacific is witnessing rapid growth due to increasing awareness about personal care and the rising middle-class population seeking advanced skincare treatments.

Market Forecast

The oligomeric hyaluronic acid market is expected to grow significantly over the next decade, with a compound annual growth rate (CAGR) of approximately 7-8%. The cosmetic segment is expected to hold the largest share due to the growing adoption of anti-aging products. The medical segment is also projected to expand with the increasing adoption of injectable hyaluronic acid therapies for joint health and cosmetic procedures.

Conclusion

Oligomeric hyaluronic acid is a crucial component in both the cosmetic and medical industries due to its hydrating, anti-aging, and therapeutic benefits. With increasing consumer demand for both beauty and health-related applications, this market is poised for continued growth, particularly in regions like North America and Asia-Pacific.

Oligomeric Hyaluronic Acid Market Segments

By Type

Food Grade

Cosmetic Grade

Pharmaceutical Grade

By Application

Medical Industry

Cosmetics Industry

Food Industry

Oligomeric Hyaluronic Acid Market Players

Givaudan Active Beauty

Kewpie Corp.

Evonik

Bloomage Biotechnology Corp., Ltd.

Focus Chem

Fufeng Group

AWA Biopharm

China Eastar Group

Contipro

Seikagaku

HTL Biotechnology

Fidia Farmaceutici

Zhejiang Green Creation Biotechnology Co., Ltd.

Shandong Liyang Biotechnology Co., Ltd.

Wanshun Chemical Materials

Others

Table of Contents

1 Research Methodology and Statistical Scope

1.1 Market Definition and Statistical Scope of Oligomeric Hyaluronic Acid

1.2 Key Market Segments

1.2.1 Oligomeric Hyaluronic Acid Segment by Type

1.2.2 Oligomeric Hyaluronic Acid Segment by Application

1.3 Methodology & Sources of Information

1.3.1 Research Methodology

1.3.2 Research Process

1.3.3 Market Breakdown and Data Triangulation

1.3.4 Base Year

1.3.5 Report Assumptions & Caveats

2 Oligomeric Hyaluronic Acid Market Overview

2.1 Global Market Overview

2.1.1 Global Oligomeric Hyaluronic Acid Market Size (M USD) Estimates and Forecasts (2019-2030)

2.1.2 Global Oligomeric Hyaluronic Acid Sales Estimates and Forecasts (2019-2030)

2.2 Market Segment Executive Summary

2.3 Global Market Size by Region

3 Oligomeric Hyaluronic Acid Market Competitive Landscape

3.1 Global Oligomeric Hyaluronic Acid Sales by Manufacturers (2019-2024)

3.2 Global Oligomeric Hyaluronic Acid Revenue Market Share by Manufacturers (2019-2024)

3.3 Oligomeric Hyaluronic Acid Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.4 Global Oligomeric Hyaluronic Acid Average Price by Manufacturers (2019-2024)

3.5 Manufacturers Oligomeric Hyaluronic Acid Sales Sites, Area Served, Product Type

3.6 Oligomeric Hyaluronic Acid Market Competitive Situation and Trends

3.6.1 Oligomeric Hyaluronic Acid Market Concentration Rate

3.6.2 Global 5 and 10 Largest Oligomeric Hyaluronic Acid Players Market Share by Revenue

3.6.3 Mergers & Acquisitions, Expansion

4 Oligomeric Hyaluronic Acid Industry Chain Analysis

4.1 Oligomeric Hyaluronic Acid Industry Chain Analysis

4.2 Market Overview of Key Raw Materials

4.3 Midstream Market Analysis

4.4 Downstream Customer Analysis

5 The Development and Dynamics of Oligomeric Hyaluronic Acid Market

5.1 Key Development Trends

5.2 Driving Factors

5.3 Market Challenges

5.4 Market Restraints

5.5 Industry News

5.5.1 New Product Developments

5.5.2 Mergers & Acquisitions

5.5.3 Expansions

5.5.4 Collaboration/Supply Contracts

5.6 Industry Policies

6 Oligomeric Hyaluronic Acid Market Segmentation by Type

6.1 Evaluation Matrix of Segment Market Development Potential (Type)

6.2 Global Oligomeric Hyaluronic Acid Sales Market Share by Type (2019-2024)

6.3 Global Oligomeric Hyaluronic Acid Market Size Market Share by Type (2019-2024)

6.4 Global Oligomeric Hyaluronic Acid Price by Type (2019-2024)

7 Oligomeric Hyaluronic Acid Market Segmentation by Application

7.1 Evaluation Matrix of Segment Market Development Potential (Application)

7.2 Global Oligomeric Hyaluronic Acid Market Sales by Application (2019-2024)

7.3 Global Oligomeric Hyaluronic Acid Market Size (M USD) by Application (2019-2024)

7.4 Global Oligomeric Hyaluronic Acid Sales Growth Rate by Application (2019-2024)

8 Oligomeric Hyaluronic Acid Market Segmentation by Region

8.1 Global Oligomeric Hyaluronic Acid Sales by Region

8.1.1 Global Oligomeric Hyaluronic Acid Sales by Region

8.1.2 Global Oligomeric Hyaluronic Acid Sales Market Share by Region

8.2 North America

8.2.1 North America Oligomeric Hyaluronic Acid Sales by Country

8.2.2 U.S.

8.2.3 Canada

8.2.4 Mexico

8.3 Europe

8.3.1 Europe Oligomeric Hyaluronic Acid Sales by Country

8.3.2 Germany

8.3.3 France

8.3.4 U.K.

8.3.5 Italy

8.3.6 Russia

8.4 Asia Pacific

8.4.1 Asia Pacific Oligomeric Hyaluronic Acid Sales by Region

8.4.2 China

8.4.3 Japan

8.4.4 South Korea

8.4.5 India

8.4.6 Southeast Asia

8.5 South America

8.5.1 South America Oligomeric Hyaluronic Acid Sales by Country

8.5.2 Brazil

8.5.3 Argentina

8.5.4 Columbia

8.6 Middle East and Africa

8.6.1 Middle East and Africa Oligomeric Hyaluronic Acid Sales by Region

8.6.2 Saudi Arabia

8.6.3 UAE

8.6.4 Egypt

8.6.5 Nigeria

8.6.6 South Africa

9 Key Companies Profile

9.1 Givaudan Active Beauty

9.1.1 Givaudan Active Beauty Oligomeric Hyaluronic Acid Basic Information

9.1.2 Givaudan Active Beauty Oligomeric Hyaluronic Acid Product Overview

9.1.3 Givaudan Active Beauty Oligomeric Hyaluronic Acid Product Market Performance

9.1.4 Givaudan Active Beauty Business Overview

9.1.5 Givaudan Active Beauty Oligomeric Hyaluronic Acid SWOT Analysis

9.1.6 Givaudan Active Beauty Recent Developments

9.2 Kewpie Corp.

9.2.1 Kewpie Corp. Oligomeric Hyaluronic Acid Basic Information

9.2.2 Kewpie Corp. Oligomeric Hyaluronic Acid Product Overview

9.2.3 Kewpie Corp. Oligomeric Hyaluronic Acid Product Market Performance

9.2.4 Kewpie Corp. Business Overview

9.2.5 Kewpie Corp. Oligomeric Hyaluronic Acid SWOT Analysis

9.2.6 Kewpie Corp. Recent Developments

9.3 Evonik

9.3.1 Evonik Oligomeric Hyaluronic Acid Basic Information

9.3.2 Evonik Oligomeric Hyaluronic Acid Product Overview

9.3.3 Evonik Oligomeric Hyaluronic Acid Product Market Performance

9.3.4 Evonik Oligomeric Hyaluronic Acid SWOT Analysis

9.3.5 Evonik Business Overview

9.3.6 Evonik Recent Developments

9.4 Bloomage Biotechnology Corp., Ltd.

9.4.1 Bloomage Biotechnology Corp., Ltd. Oligomeric Hyaluronic Acid Basic Information

9.4.2 Bloomage Biotechnology Corp., Ltd. Oligomeric Hyaluronic Acid Product Overview

9.4.3 Bloomage Biotechnology Corp., Ltd. Oligomeric Hyaluronic Acid Product Market Performance

9.4.4 Bloomage Biotechnology Corp., Ltd. Business Overview

9.4.5 Bloomage Biotechnology Corp., Ltd. Recent Developments

9.5 Focus Chem

9.5.1 Focus Chem Oligomeric Hyaluronic Acid Basic Information

9.5.2 Focus Chem Oligomeric Hyaluronic Acid Product Overview

9.5.3 Focus Chem Oligomeric Hyaluronic Acid Product Market Performance

9.5.4 Focus Chem Business Overview

9.5.5 Focus Chem Recent Developments

9.6 Fufeng Group

9.6.1 Fufeng Group Oligomeric Hyaluronic Acid Basic Information

9.6.2 Fufeng Group Oligomeric Hyaluronic Acid Product Overview

9.6.3 Fufeng Group Oligomeric Hyaluronic Acid Product Market Performance

9.6.4 Fufeng Group Business Overview

9.6.5 Fufeng Group Recent Developments

9.7 AWA Biopharm

9.7.1 AWA Biopharm Oligomeric Hyaluronic Acid Basic Information

9.7.2 AWA Biopharm Oligomeric Hyaluronic Acid Product Overview

9.7.3 AWA Biopharm Oligomeric Hyaluronic Acid Product Market Performance

9.7.4 AWA Biopharm Business Overview

9.7.5 AWA Biopharm Recent Developments

9.8 China Eastar Group

9.8.1 China Eastar Group Oligomeric Hyaluronic Acid Basic Information

9.8.2 China Eastar Group Oligomeric Hyaluronic Acid Product Overview

9.8.3 China Eastar Group Oligomeric Hyaluronic Acid Product Market Performance

9.8.4 China Eastar Group Business Overview

9.8.5 China Eastar Group Recent Developments

9.9 Contipro

9.9.1 Contipro Oligomeric Hyaluronic Acid Basic Information

9.9.2 Contipro Oligomeric Hyaluronic Acid Product Overview

9.9.3 Contipro Oligomeric Hyaluronic Acid Product Market Performance

9.9.4 Contipro Business Overview

9.9.5 Contipro Recent Developments

9.10 Seikagaku

9.10.1 Seikagaku Oligomeric Hyaluronic Acid Basic Information

9.10.2 Seikagaku Oligomeric Hyaluronic Acid Product Overview

9.10.3 Seikagaku Oligomeric Hyaluronic Acid Product Market Performance

9.10.4 Seikagaku Business Overview

9.10.5 Seikagaku Recent Developments

9.11 HTL Biotechnology

9.11.1 HTL Biotechnology Oligomeric Hyaluronic Acid Basic Information

9.11.2 HTL Biotechnology Oligomeric Hyaluronic Acid Product Overview

9.11.3 HTL Biotechnology Oligomeric Hyaluronic Acid Product Market Performance

9.11.4 HTL Biotechnology Business Overview

9.11.5 HTL Biotechnology Recent Developments

9.12 Fidia Farmaceutici

9.12.1 Fidia Farmaceutici Oligomeric Hyaluronic Acid Basic Information

9.12.2 Fidia Farmaceutici Oligomeric Hyaluronic Acid Product Overview

9.12.3 Fidia Farmaceutici Oligomeric Hyaluronic Acid Product Market Performance

9.12.4 Fidia Farmaceutici Business Overview

9.12.5 Fidia Farmaceutici Recent Developments

9.13 Zhejiang Green Creation Biotechnology Co., Ltd.

9.13.1 Zhejiang Green Creation Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Basic Information

9.13.2 Zhejiang Green Creation Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Product Overview

9.13.3 Zhejiang Green Creation Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Product Market Performance

9.13.4 Zhejiang Green Creation Biotechnology Co., Ltd. Business Overview

9.13.5 Zhejiang Green Creation Biotechnology Co., Ltd. Recent Developments

9.14 Shandong Liyang Biotechnology Co., Ltd.

9.14.1 Shandong Liyang Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Basic Information

9.14.2 Shandong Liyang Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Product Overview

9.14.3 Shandong Liyang Biotechnology Co., Ltd. Oligomeric Hyaluronic Acid Product Market Performance

9.14.4 Shandong Liyang Biotechnology Co., Ltd. Business Overview

9.14.5 Shandong Liyang Biotechnology Co., Ltd. Recent Developments

9.15 Wanshun Chemical Materials

9.15.1 Wanshun Chemical Materials Oligomeric Hyaluronic Acid Basic Information

9.15.2 Wanshun Chemical Materials Oligomeric Hyaluronic Acid Product Overview

9.15.3 Wanshun Chemical Materials Oligomeric Hyaluronic Acid Product Market Performance

9.15.4 Wanshun Chemical Materials Business Overview

9.15.5 Wanshun Chemical Materials Recent Developments

10 Oligomeric Hyaluronic Acid Market Forecast by Region

10.1 Global Oligomeric Hyaluronic Acid Market Size Forecast

10.2 Global Oligomeric Hyaluronic Acid Market Forecast by Region

10.2.1 North America Market Size Forecast by Country

10.2.2 Europe Oligomeric Hyaluronic Acid Market Size Forecast by Country

10.2.3 Asia Pacific Oligomeric Hyaluronic Acid Market Size Forecast by Region

10.2.4 South America Oligomeric Hyaluronic Acid Market Size Forecast by Country

10.2.5 Middle East and Africa Forecasted Consumption of Oligomeric Hyaluronic Acid by Country

11 Forecast Market by Type and by Application (2025-2030)

11.1 Global Oligomeric Hyaluronic Acid Market Forecast by Type (2025-2030)

11.1.1 Global Forecasted Sales of Oligomeric Hyaluronic Acid by Type (2025-2030)

11.1.2 Global Oligomeric Hyaluronic Acid Market Size Forecast by Type (2025-2030)

11.1.3 Global Forecasted Price of Oligomeric Hyaluronic Acid by Type (2025-2030)

11.2 Global Oligomeric Hyaluronic Acid Market Forecast by Application (2025-2030)

11.2.1 Global Oligomeric Hyaluronic Acid Sales (Kilotons) Forecast by Application

11.2.2 Global Oligomeric Hyaluronic Acid Market Size (M USD) Forecast by Application (2025-2030)

12 Conclusion and Key Findings

Oligomeric Hyaluronic Acid Market Segments

By Type

Food Grade

Cosmetic Grade

Pharmaceutical Grade

By Application

Medical Industry

Cosmetics Industry

Food Industry

Oligomeric Hyaluronic Acid Market Players

Givaudan Active Beauty

Kewpie Corp.

Evonik

Bloomage Biotechnology Corp., Ltd.

Focus Chem

Fufeng Group

AWA Biopharm

China Eastar Group

Contipro

Seikagaku

HTL Biotechnology

Fidia Farmaceutici

Zhejiang Green Creation Biotechnology Co., Ltd.

Shandong Liyang Biotechnology Co., Ltd.

Wanshun Chemical Materials

Others

Similar Reports